×
Choose Speciality

EXPLORE!

LOGIN

By signing up or signing in to eMediNexus, you consent to eMediNexus collecting and using your personal data in accordance with our Privacy Policy. We are committed to safeguarding your information and ensuring the highest standards of data protection. Your trust and privacy are of utmost importance to us.

Antithyroid drugs given in first trimester increase risk for congenital malformations

  918 Views

eMediNexus    23 January 2018

Women who received antithyroid drugs (methimazole and propylthiouracil), for Graves’ disease during the first trimester of pregnancy are at increased risk of their infants being born with congenital malformations, suggests a study published online January 23, 2018 in Annals of Internal Medicine.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.